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Correspondence should be addressed to Zerrin Pelin; zerrinp@gmail.com
Received 25 February 2016; Accepted 15 May 2016
Academic Editor: Yolande Pijnenburg
Copyright © 2016 Itır Tarı Cömert et al.This is an open access article distributed under theCreative CommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aim of this study was to assess the validity and reliability of a Turkish version of the rapid eye movement sleep behavior
disorder questionnaire (the RBDSQ-T) for identifying patients with rapid eye movement sleep behavior disorder (RBD) and to
ensure that this tool can be applied in Turkish language. Three groups were enrolled to validate the RBDSQ-T: 78 healthy controls,
17 patients previously diagnosed with RBD, and 28 patients with obstructive sleep apnea syndrome (OSAS). Based on a cut-off
score of five, the RBDSQ-T was able to discriminate RBD patients from healthy controls with sensitivity of 100% and specificity of
87%. Accordingly, 63% of patients were correctly diagnosed using the RBDSQ-T. Similarly, with a cut-off score of five, the RBDSQ-
T was able to discriminate RBD from OSAS with sensitivity of 100% and specificity of 64%. Assessment of test-retest reliability
and internal consistency reliability using Kuder-Richardson 20 analysis revealed a test-retest correlation coefficient of 0.95 and a
Kuder-Richardson 20 value of 0.82. The findings demonstrate that the RBDSQ-T is a valid and reliable tool.
1. Introduction
Rapid eye movement sleep behavior disorder (RBD) is char-
acterized by actions during rapid eyemovement (REM) sleep,
such as talking, shouting, kicking, standing up, and even
falling out of bed. These actions occur due to intermittent
loss of muscle atonia which is normally associated with
REM sleep, and affected patients move in accord with their
dream contents [1]. Dream content for RBDpatients is usually
unpleasant and violent; the disorder is problematic in that
patients and their sleeping partners may become injured by
such violent and even life-threatening behaviors [2].
According to the International Classification of Sleep
Disorders-II (ICSD-II), diagnosis of RBD requires video-
polysomnographic evidence of the absence of atonia associ-
ated with movements during REM sleep [3]. However, video-
polysomnography is not a practical method to screen RBD
patients at population scale. An easily applicable and practical
method is needed to diagnose this disorder. To address this,
Stiasny-Kolster developed a questionnaire for screeningRBD,
the REM sleep behavior disorder questionnaire (RBDSQ),
which was published in English andGerman versions in 2007
[4]. Subsequently, this instrument was also validated for the
Japanese population as a screening tool for RBD [5].
The exact prevalence of RBD has not yet been clearly
documented, but studies conducted on different age groups
of elderly people in Hong Kong have revealed an estimated
range of 0.38% to 0.50% [6, 7]. Another investigation of 70-
year-old or older residents of Hong Kong indicated an esti-
mated RBD prevalence of 0.38% based on polysomnographic
data [8]. According to data obtained from a 2013 census in
Turkey, nearly 6 million people in this country are now older
than 65 years of age [9]. Based on an estimated prevalence of
0.38% there are approximately 23,000 cases of RBD in Turkey
currently.
Rapid eye movement sleep behavior disorder is recog-
nized as one of the most common causes of sleep-related vio-
lence [10].The potential for injury to oneself or a bed partner
raises difficult forensic medicine questions. Violent behavior
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during sleep is a rare occurrence but one with troubling
implications for adjudicating criminal responsibility. Apart
from the medical and legal implications, RBD carries the
clinical significance of being an early precursor of neurode-
generative process. Hence, early detection and intervention
are very important in cases of RBD. Several established RBD
scales provide aids for screening, diagnosing, andmonitoring
treatment progress and response. However, to date, there has
been no validated, reliable Turkish scale to diagnose this
disorder. The aim of this study was to assess the validity and
reliability of a Turkish version of the RBDSQ and to ensure
that this tool can be applied in Turkish language.
2. Materials and Methods
To create the Turkish adaptation of the RBDSQ, the objectives
of this study were explained to RBDSQ developer Stiasny-
Kolster, who consented to have the original version translated
into Turkish and establish the first RBDSQ-T. Once this was
done, an interpreter who was not specialized in medicine
translated the Turkish version back into English.The authors
of the original RBDSQ were then asked to confirm that the
back-translated English document was equivalent to content
of the original version. They did so and also gave consent
for its use in this study. The instrument was then sent to
three experts in Turkey working in different departments of
sleep medicine centers, and these individuals agreed that the
instrument was applicable for RBD patients in Turkey.
The study was approved by the ethics committee of Hasan
Kalyoncu University. It involved three groups: (1) 78 ran-
domly selected healthy controls with no symptoms or history
of sleep disorders and no neurological or psychiatric disease,
(2) 17 patients previously diagnosed with RBD, and (3) 28
consecutive patients who had been diagnosed with obstruc-
tive sleep apnea syndrome (OSAS) but were not treated
with continuous positive airway pressure (CPAP) prior to
the study. The RBD and OSAS patients were recruited from
individuals who were referred to the sleep clinic between
January 2013 and August 2014. Obstructive sleep apnea syn-
drome was diagnosed according to the criteria of American
Academy of Sleep Medicine [3], and apnea-hypopnea index
greater than 5 per hour was accepted to indicate OSAS.
For a patient to be enrolled in the OSAS group, other
sleep disorders (e.g., RBD, restless legs syndrome, periodic
limb movement disorders, and narcolepsy) were excluded by
polysomnography and clinical interview. Polysomnographic
evaluation was not performed on the healthy subjects.
All 123 enrolled participants self-rated the RBDSQ-T
(preliminary test) during their first visit and were asked to
retest them 2.5 months later. The RBDSQ-T comprises 10
itemswith yes/no questions that address frequency of dreams,
dream content, nocturnal movements, injuries to self or bed
partner, types of motor behaviors during the night, nocturnal
awakenings, sleep disruption, and presence of a neurological
disease. Since not all patients have a long-time companion,
the bed partner’s input was encouraged but not required.
Items 1 to 4 address the frequency and content of dreams
and their relationship to nocturnal movements and behavior.











Males 12 (70.6%) 19 (67.9%) 21 (26.9%) 52 (42.3%)
Females 5 (29.4%) 9 (32.1%) 57 (73.1%) 71 (57.7%)
Age
30–45 years — 10 (35.7%) — 74 (60.2%)
46–60 years 2 (11.8%) 15 (53.7%) 14 (17.9%) 31 (25.2%)
>60 15 (88.2%) 3 (10.7%) 64 (82.1%) 18 (14.6%)
OSAS: obstructive sleep apnea syndrome; RBD: rapid eye movement (REM)
sleep behavior disorder.
Item 5 asks about self-injuries and bed partner injuries.
Item 6 consists of four subitems that assess nocturnal motor
behavior more specifically and questions about nocturnal
vocalization, sudden limb movements, complex movements,
or items which a bed partner would need to provide answers
regarding RBD events. Items 7 and 8 deal with nocturnal
awakenings. Item 9 focuses on disturbed sleep in general, and
item 10 focuses on the presence of any neurological disorder.
Statistical analyses were performed using SPSS 17.0. Gen-
eral linear model (GLM) univariate analysis of variance was
used to compare group results, and the Scheffe multiple com-
parisons test was used if 𝐹 value in GLM was significant. The
diagnostic value of the RBDSQ-T was calculated using area
under the curve (AUC) analysis. Test-retest reliability and
internal consistency reliability were assessed using Kuder-
Richardson (KR) 20 analysis. Descriptive data were presented
as means ± standard deviations for continuous variables and
as frequencies for categorical variables.
3. Results
The17RBDpatients were five females and 12males withmean
age of 68.6 ± 6.3 years (range, 55–77 years). The 28 untreated
OSAS patients were nine females and 19 males with mean
age of 50.0 ± 10.8 years (range, 34–77 years), and the average
apnea-hypopnea index was 32.5 ± 26.0 per hour. Two RBD
patients had Parkinson’s disease and three had dementia.The
78 controls were 57 females and 21 males with mean age
of 40.0 ± 6.9 years (range, 30–58 years). Of the 123 total
participants, 71 (57.7%) were women and 52 (42.3%) were
men. The subjects’ main demographic features are shown in
Table 1.
The Scheffe multiple comparisons test indicated that the
mean RBDSQ-T score for the RBD group (9.35 ± 1.58; range,
6–12) was significantly higher than the mean scores for the
OSAS group (4.07 ± 2.87; range, 1–12) and healthy controls
(2.86 ± 2.15; range, 1–12). The mean score for the RBD group
was higher than five, which was defined as the cut-off point
for diagnosis of RBD.
When the 123 participants were categorized by sex, the
total RBDSQ-T scores for the men were significantly higher
































Figure 1: (a) Graph shows the receiver operating characteristic (ROC) curve for the rapid eye movement sleep behavior disorder (RBD)
group versus the healthy control group. Area under the curve (AUC) = 0.974 (95% CI: 0.936–1.00; 𝑝 = 0.001). (b) Graph shows the ROC for
the RBD group versus the obstructive sleep apnea syndrome (OSAS) group. AUC = 0.921 (95% CI: 0.826–1.00; 𝑝 = 0.001).






















controls 5 100 87 63 100 53.67
0.97
(0.93–1.00) 0.001
OSAS group 5 100 64 63 100 24.07 0.92(0.82–1.00) 0.001
AUC: receiver operating characteristic area under curve; RBD: rapid eye movement (REM) sleep behavior disorder; OSAS: obstructive sleep apnea syndrome.
mean score for women was significantly lower than that for
men (3.17 ± 2.50 versus 5.21 ± 3.56, resp.; 𝑝 = 0.001).
Within the RBD andOSAS groups, respectively, themean
RBDSQ-T scores for men and women were not significantly
different (𝑡(15) = 1.69, 𝑝 = 0.110 for RBD; 𝑡(26) = 0.89,
𝑝 = 0.379 for OSAS). Within the control group, the mean
RBDSQ-T score for men was significantly higher than that
for women (𝑡(76) = 2.84, 𝑝 = 0.006).
Since the distribution of data was normal and variances
were homogenous, we performed GLM univariate analysis of
variance to compare findings among the RBD group, OSAS
group, and healthy group. The results revealed significant
differences among these three (𝐹(2, 120) = 57.04, 𝑝 = 0.001,
and 𝜂2 = 0.49).
Table 2 and Figure 1 demonstrate that, based on a cut-
off score of five, the RBDSQ-T was able to discriminate RBD
patients from healthy controls with sensitivity of 100% and
specificity of 87%. Accordingly, 63% patients were correctly
diagnosed using the RBDSQ-T. Similarly, with a cut-off score
of five, the RBDSQ-T was able to discriminate RBD patients
from OSAS patients with sensitivity of 100% and specificity
of 64%.
The diagnostic value of the RBDSQ-T was calculated
using the AUC, which was independent of an arbitrary choice
of a cut-off point.The resultant values were 0.974 (95% confi-
dence interval (CI): 0.936–1.00) for comparison of the healthy
group and the RBD group and 0.921 (95% CI: 0.826–1.00) for
comparison of the OSAS group and the RBD group. Single-
itemanalysis revealed the highest specificity for questionnaire
items 5, 7, and 10 in comparison with the healthy controls
and for items 6.4, 6.3, and 5 in comparison with the OSAS
group (Table 3). Regarding test-retest reliability and internal
consistency reliability, the test-retest correlation coefficient
was 0.95 and the Kuder-Richardson 20 value was 0.82.
4. Discussion
The RBDSQ is a concise tool that was developed to assist the
clinical evaluation of patients with dream-related behaviors.
This self-rating, 13-item questionnaire covers several aspects
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Table 3: Sensitivity and specificity of the Turkish version of the rapid eye movement sleep behavior disorder questionnaire items.
RBDSQ-T item










(1) I sometimes have very vivid
dreams. 100 100 21.79 25 21.79 44.74 100 100
(2) My dreams frequently have an
aggressive or action-packed content. 88.24 88.24 87.18 82.14 60 75 97.14 92
(3) The dream contents mostly
match my nocturnal behavior. 88.24 88.24 83.33 82.14 53.57 75 97.01 92
(4) I know that my arms or legs
move when I sleep. 29.41 29.41 78.21 46.43 22.73 25 83.56 52
(5) It thereby happened that I
(almost) hurt my bed partner or
myself.
94.12 94.12 97.44 85.71 88.89 80 98.7 96
(6) I have or had the following
phenomena during my dreams:
(6.1) Speaking, shouting,
swearing, laughing loudly. 82.35 82.35 67.95 75 35.9 66.67 94.64 87.5
(6.2) Sudden limb movements,
“fights.” 82.35 82.35 88.46 75 60.87 66.67 95.83 87.5
(6.3) Gestures, complex
movements, that are useless
during sleep, for example, to
wave, to salute, to frighten
mosquitoes, falls off the bed.
88.24 88.24 87.18 85.71 60 78.95 97.14 92.31
(6.4) Things that fell down
around the bed, for example,
bedside lamp, book, glasses. . .and
so forth.
47.06 47.06 92.31 89.29 57.14 72.73 88.89 73.53
(7) It happens that my movements
awake me. 64.71 64.71 94.87 78.57 73.33 64.71 92.5 78.57
(8) After awakening I mostly
remember the content of my
dreams well.
100 100 87.18 35.71 62.96 48.57 100 100
(9) My sleep is frequently disturbed. 41.18 41.18 34.62 64.29 12.07 41.18 72.97 64.29
(10) I have/had a disease of the
nervous system (stroke, head
trauma, parkinsonism, RLS,
narcolepsy, depression, epilepsy,
inflammatory disease of the brain),
which?
29.41 29.41 93.59 67.86 50 35.71 85.88 61.29
RBDSQ-T: RBD screening questionnaire-Turkish version; RBD: rapid eyemovement (REM) sleep behavior disorder; OSAS: obstructive sleep apnea syndrome.
of sleep- and REM-related behavior, but in some cases bed
partners or caregivers information can be needed to cross-
check the situation. During our study we did not have that
change to do this; all of the participants of research gave their
information themselves. And this is one of the limitations of
our study, but also other studies have got the same limitations.
Our validation study revealed that the Turkish version of
the RBDSQ is useful for differentiating RBD patients from
OSAS patients and healthy subjects in Turkey. A total score of
five was found to be the best cut-off for differentiating RBD
patients from healthy controls and OSAS patients.
The mean RBDSQ-T score for the RBD group was 9.3
± 2.8, which is very close to that noted for the patient
group in the original study (9.5 ± 2.8) [4]. The mean score
for our RBD group was also higher than corresponding
scores in Chinese and Japanese validation studies (8.05 ±
2.46 and 7.5 ± 2.8, resp.) [5, 11]. Even though our study
group comprised heterogeneous RBDpatients (including two
with Parkinson’s disease and three with dementia), our RBD
patients’ mean total score was higher than scores for relevant
subgroups in the Chinese study by Wang et al. (8.07 ± 2.71
for symptomatic RBD and 7.95 ± 1.90 for RBD patients
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with Parkinson’s disease) [11]. Those authors concluded that
their results reflected differences in symptoms between Asian
and European cohorts. Our findings could reflect that the
symptoms of RBD in the Turkish population are similar to
those that affect European subjects.
Concerning the diagnostic value of the RBDSQ-T,
patients with RBD had a significantly higher score for this
(9.35 ± 1.58) than the OSAS and control groups (4.07 ± 2.87
and 2.86± 2.15, resp.). A cut-off score of five for the RBDSQ-T
yielded high sensitivity (100%) but low specificity (64%) for
distinguishingRBDpatients from thosewithOSAS.The same
cut-off score yielded high sensitivity and specificity (100%
and 87%, resp.) for discriminating RBD patients from healthy
subjects. A Japanese validation study of the RBDSQ-J [5]
showed that a cut-off score of 4.5 yielded very high specificity
for differentiating RBD patients from OSAS patients who
were under continuous positive airway pressure (CPAP)
treatment. The OSAS patients in our study had not been
treated, and, in such patients, physical movements during
sleep which are associated with abnormal respiratory events
can be difficult to differentiate from movements of RBD.
The difference in specificity between the Japanese results and
ours may be explained by the fact that the Japanese OSAS
group had been treated [5]. A Korean validation study of
the RBDSQ [12] revealed that a cut-off score of 6.5 yielded
high specificity (93.4%) for discriminatingRBDpatients from
untreated OSAS patients. In that investigation, the mean
apnea-hypopnea index of patients with idiopathic RBD was
14.8, and this might explain the higher cut-off value and
higher specificity compared to our study, in which the RBD
patients’ apnea-hypopnea index was below 5.
The mean age of our 123 total patients was 46.2 ± 12.6
years.The average age of theRBDpatientswas 68.6± 6.3 years
(range, 55–77 years), that of the healthy group was 40.0 ± 6.9
years (range, 30–58 years), and that of the OSAS patients was
50.0 ± 10.8 years (range, 34–77 years). The average ages of
groups in the noted Japanese study by Miyamoto et al. also
differed [5]: the mean age of the RBD patients was 66.4 ±
6.9 years, that of the healthy group was 64.6 ± 8.8 years, and
that of the OSAS patients was 63.1 ± 7.0 years. In the original
questionnaire [4], the average ages of the healthy group and
RBD group were 50.8 ± 15.5 years and 53.7 ± 15.8 years,
respectively. The mean age of our RBD group was similar to
the means reported in other studies.
The questionnaire items with most powerful predictive
ability were item 8 (100% predictive ability), item 5 (96%),
item 6.3 (92.3%), items 2 and 3 (92%), and items 6.1 and
6.2 (87.5%). Because items 2 and 3 address the frequency
and content of dreams and their relationship to nocturnal
movements and behavior, the answers to these are indicators
of RBD. Items 5, 6.1, and 6.2 are related to limb movements
and are, therefore, also indicators of RBD. Items 5, 6.1, 6.2, and
6.3 must be answered by bed partners, and we were unable to
contact bed partners for each of our participants. Item 8 was
a self-report and was difficult to define without bed partners’
answers. In the Japanese study [5], Miyamoto et al. found that
questionnaire items 1, 2, 5, and 6.1 were the most powerful
items.
There are a number of existing scales like Mayo Sleep
Questionnaire, RBDQ-Hong Kong (RBDQ-HK), and RBD
Single-Question Screen (RBD1Q) for screening andmonitor-
ing RBD features [8, 13, 14]. Each of these questionnaires has
strong and weak properties. In our study, we prefer RBDSQ
because it is easy to administer and can be completed by
patients themselves within some points encouraged by bed
partners or caregivers; usage of this questionnaire as a screen-
ing method demonstrated validity when compared to OSA
patients and healthy controls [5]. The weak points of RBDSQ
are as follows: not used in monitoring purposes and needs
for investigation in differentiating RBD fromparasomnia and
epilepsy patients [15]. Mayo Sleep Questionnaire is also an
easy to administer tool that was completed by bed partners
or caregivers [16]. It has questions that might be possible to
differentiate RBD from OSA patients. But its application to
only patients with cognitive impairments and the fact that
there is no information about differentiation from other sleep
disorders make this questionnaire limited. Also information
taking only bed partners creates questions about self-reports
in community usage as a screening method. RBDQ-HK [8]
is a more detailed questionnaire for both screening and
monitoring RBD and is a very strong questionnaire. Its
validation was made in a large scale of patients (RBD, RBD
with comorbidwith narcolepsy/neurodegenerative disorders,
other sleep disorders, and psychiatric patients) and healthy
subjects. It is completed by patients and/or bed partners.
Its weak point is that it has low sensitivity in differentiating
RBD from non-REM parasomnia. RBDQ1 was very sensitive
(93.8%), specific (87.2), and easily applicable single-question
questionnaire answered by patients encouraged by bed part-
ners or caregivers [14]. But taking RBD patients with a severe
symptom from sleep clinic into the validation study and
not evaluating non-REM parasomnia patients weaken this
questionnaire.
Cronbach’s alpha value for the original questionnaire
was 0.088 [4], and the corresponding value in the noted
Japanese study was 0.086 [5]; Nomura et al. administered
the RBDSQ to patients with Parkinson’s disease and found
Cronbach’s alpha to be 0.073 [17]. In our study, because
the scale scoring was derived from yes/no questions (i.e.,
dichotomous scoring), it was considered more appropriate
to perform internal consistency reliability analysis using the
KR 20 formula instead of Cronbach’s alpha. We calculated an
internal consistency coefficient of 0.082, which shows that the
scale has good internal consistency and that the measuring
instrument is reliable.
In conclusion, our findings indicate that the RBDSQ-T is
a valid and reliable tool. Comparison of the preliminary test
and retest data revealed that the Turkish version of the scale
is valid and reliable. RBDSQ-T is a screening questionnaire
for the likelihood of harbouring a diagnosis of RBD patients.
At that point the questionnaire is only a screening tool and
for further confirmatory sleep assessment performing video-
polysomnography (v-PSG) will be needed. Nonetheless, this
screening questionnairemay help to prioritize the assessment
of RBD. For legal perspective, RBD is one of several disor-
ders that can manifest as violent sleep- and dream-related
behaviors with forensic and legal implications. In the light of
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this information, our findings are also important with respect
to being able to identify RBD patients who are unknowingly
physically violent with their bed partners while sleeping and
who may be prosecuted within the justice system for such
actions. There is a major loophole in the Turkish judicial
system with respect to identifying these patients, and use of
the RBDSQ-T could help to determine competence to stand
trial in these cases. Apart from themedical and legal implica-
tions, RBD carries the clinical significance of being an early
precursor of neurodegenerative process. Therefore, early
detection and intervention of RBD are the most important
steps in this process [13]. Our study also indicates that this
scale is a valid and reliable instrument for identifying RBD
patients in Turkish language. The availability of a simple and
valid screening tool is necessary for both clinical and research
purposes; RBDSQ-T could be a significant contribution for
researchers in the fields of forensic and criminal psychology,
specifically within the judicial system and forensic sciences,
as well as for sleep researchers, clinical psychologists, and
clinicians in the fields of neurology and sleep.
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